Medtronic Has Received CE Mark Approval For Its Inceptiv Closed-Loop Rechargeable Spinal Cord Stimulator To Treat Chronic Pain
Portfolio Pulse from Benzinga Newsdesk
Medtronic has received CE Mark approval for its Inceptiv closed-loop rechargeable spinal cord stimulator, a device designed to treat chronic pain.
August 25, 2023 | 12:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Medtronic's Inceptiv spinal cord stimulator has received CE Mark approval, which could potentially boost the company's market share in the chronic pain treatment sector.
The CE Mark approval allows Medtronic to market and sell its Inceptiv device in the European Economic Area. This could potentially increase the company's revenues and market share in the chronic pain treatment sector, positively impacting its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100